Digital & Innovation
Virtual cardiac program launched to reduce hospital re-admissions
A new partnership between a not-for-profit health insurer and an Australian digital health company is set to transform cardiac care […]
MoreDigital & Innovation
Health data without borders: Can reform go beyond rhetoric?
Research Australia and the Digital Health CRC (DHCRC) have ramped up calls for a nationally coordinated approach to health data, […]
MoreDigital & Innovation
Navigating telehealth’s crowded rulebook: New consortium adds its voice to the mix
A newly formed Consortium of telehealth providers and private health insurers has come together to develop national standards for the […]
MoreDigital & Innovation
Australia enters next era of digital health transformation
The Australian Digital Health Agency (ADHA) has unveiled its new initiative, Health Connect Australia, alongside the release of its Strategy, […]
MoreDigital & Innovation
Cracking the 60% problem: AI tailors chemotherapy dosing for Aussies with bowel cancer
University of Melbourne and Western Health researchers have pioneered an innovative artificial intelligence (AI) tool aimed at preventing inaccuracies in […]
MoreDigital & Innovation
AI voice technology to target diabetes risk
Type 2 diabetes (T2D) is a global epidemic, affecting 496 million people worldwide and 1.3 million Australians. Alarmingly, it is […]
MoreDigital & Innovation
First-of-its-kind partnership brings GP care to pharmacy doors around the clock
National Pharmacies has partnered with a primary healthcare provider to offer consumers 24/7 access to GPs, following a successful trial […]
MoreDigital & Innovation
Reimagining remote care with Australia’s first virtual hospital
Australia’s first virtual hospital is taking on a new role as a national testbed for advancing the future of patient-facing […]
MoreDigital & Innovation
Australian-first digital mental health program: Success hinges on fixing critical flaws before rollout
A $135.2 million government investment into the Digital Mental Health Program will see 12 mental health services provide Australians access […]
MoreDigital & Innovation
Government tool to set standards for risk and safety in healthcare AI solutions
A new initiative is set to redefine how artificial intelligence (AI) solutions are classified and adopted in Australian healthcare. The […]
MoreRecent Posts in Pharma, MedTech & Biotech
Is Australia any closer to the negotiation table on U.S. medicines pricing?
August 15, 2025
in News - Pharmaceuticals
Balancing the scales: Why are we missing the mark on diabetes?
August 15, 2025
in Medical and Science
Bridging the bench and boardroom: Rethinking innovation in aggressive breast cancer
August 15, 2025
in Medical and Science
Blood biomarker pinpoints patients for LuPSMA therapy in prostate cancer
August 13, 2025
in News - Pharmaceuticals
Australia’s first robotic system delivers complex surgery with just one tiny cut
August 13, 2025
in News - MedTech & Diagnostics
Can AI bridge HTA workforce gaps and budget black hole?
August 13, 2025
in News - Pharmaceuticals
Amgen’s race to recharge the pulse of R&D: National Science Week
August 12, 2025
in Medical and Science
Leadership shift sets Biogen ANZ on course for next-phase growth
August 12, 2025
in Leadership & Management
Follow Us
Partner with us
News - Pharmaceuticals
Is Australia any closer to the negotiation table on U.S. medicines pricing?
The U.S. tariff debate, alongside pressure for a ‘Most-Favored-Nation’ pricing model, continues to cast uncertainty over government policy and industry […]
MoreMedical and Science
Balancing the scales: Why are we missing the mark on diabetes?
As Australia marks National Science Week, two of the nation’s leading voices in diabetes research and policy sit down to […]
MoreMedical and Science
Bridging the bench and boardroom: Rethinking innovation in aggressive breast cancer
Coinciding with National Science Week podcast, Andrew Parry, Associate Director of Global Medical Strategy & Operations at Gilead Sciences and […]
MoreNews - Pharmaceuticals
Blood biomarker pinpoints patients for LuPSMA therapy in prostate cancer
A blood test is set to predict which advanced prostate cancer patients will respond to the radioligand therapy 177-Lutetium prostate-specific […]
More